Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Clinical trial NCT00974311 · COMPLETED
Trial details
- NCT number
- NCT00974311
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-30
- Primary completion
- 2011-09-15
- Enrollment
- 1199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.